{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/seborrhoeic-dermatitis/","result":{"data":{"firstChapter":{"id":"2c32aabf-f751-57c2-9fb1-bfd7e4c7e58d","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 2a2ec451-bfe7-422b-aa31-e94b764b003a --><h1>Seborrhoeic dermatitis: Summary</h1><!-- end field 2a2ec451-bfe7-422b-aa31-e94b764b003a -->","htmlStringContent":"<!-- begin item 624f1114-ed79-456b-9861-b0b0a11932bc --><!-- begin field d3c2cb0c-7ff5-4b4c-9678-6e8631fcbcb1 --><ul><li>Seborrhoeic dermatitis is a common inflammatory skin condition occurring in areas rich in sebaceous glands (such as the scalp, nasolabial folds, eyebrows, and chest). In infants the scalp is most commonly affected ('cradle cap').<ul><li>It typically presents as erythematous patches with scale which may be white or yellow, oily or dry.</li><li>The exact cause of seborrhoeic dermatitis is not fully understood; many factors including the presence of Malassezia yeasts and host immune response have been associated with its development.</li></ul></li><li>Infantile seborrhoeic dermatitis is usually self-limiting and resolves by four months of age. In adults, seborrhoeic dermatitis is a chronic condition — symptoms fluctuate over time and are likely to recur after treatment stops.</li><li>Diagnosis is usually clinical. Investigations (such as blood tests, skin scrapings, or skin biopsy) may be appropriate if an underlying cause (such as HIV) or an alternative diagnosis (such as tinea or lupus) is suspected.</li><li>Management of seborrhoeic dermatitis in infants involves:<ul><li>Giving advice on simple measures such as softening of scales with emollient, gentle brushing to loosen scales and washing of the scalp with baby shampoo.</li><li>If these are not effective, an imidazole cream can be used. If symptoms persist longer than 4 weeks with treatment, specialist advice should be sought.</li><li>Topical corticosteroids are not usually advised, although they may be of use for certain infants with seborrhoeic dermatitis in association with nappy rash.</li></ul></li><li>Management of seborrhoeic dermatitis of the scalp and beard includes:<ul><li>Use of ketoconazole 2% shampoo (in adolescents and adults), selenium sulphide shampoo, or an over the counter anti-dandruff shampoo (for example containing coal tar or salicylic acid) — shampoo should be left on for 5 minutes before rinsing off.</li><li>For adults with severe itching of the scalp, a potent topical corticosteroid scalp application (such as betamethasone valerate 0.1% scalp application) can be added for 4 weeks.</li></ul></li><li>Management of seborrhoeic dermatitis of the face and body involves:<ul><li>Application of ketoconazole 2% cream (adults only) or other topical imidazoles (such as clotrimazole or miconazole) — an antifungal shampoo such as ketoconazole 2% can be used as a body wash in adolescents and adults.</li><li>Addition of a mild topical corticosteroid cream such as hydrocortisone 1% for flares to settle inflammation.</li></ul></li><li>Severe or widespread seborrhoeic dermatitis in children should be discussed urgently with paediatrics or dermatology to consider serious underlying causes such as immunodeficiency.</li><li>Management of severe or widespread seborrhoeic dermatitis in adults involves:<ul><li>Consideration of alternative diagnoses such as psoriasis, systemic lupus erythematosus or infected eczema.</li><li>Consideration of whether the person may be immunocompromised (for example has HIV infection) and the need for further investigations.</li><li>Referral to a dermatologist and seeking specialist advice on what treatment is needed while the person is waiting to be seen.</li></ul></li><li>Referral to a dermatologist/paediatrician should be considered if there is:<ul><li>Diagnostic uncertainty.</li><li>Failure to respond to routine treatment.</li><li>Severe or widespread seborrhoeic dermatitis.</li><li>Eyelid involvement (if eyelid hygiene measures have been unsuccessful).</li></ul></li></ul><!-- end field d3c2cb0c-7ff5-4b4c-9678-6e8631fcbcb1 --><!-- end item 624f1114-ed79-456b-9861-b0b0a11932bc -->","topic":{"id":"b328d01a-a44a-57e1-8920-22321b4c6c8b","topicId":"67c69cb5-e030-443e-802f-758ce0fe90f8","topicName":"Seborrhoeic dermatitis","slug":"seborrhoeic-dermatitis","aliases":[],"chapters":[{"id":"2c32aabf-f751-57c2-9fb1-bfd7e4c7e58d","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"96bfb0b4-09f0-5525-aaf3-ca2354a87cb4","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"9bf8c16e-f128-5c6a-b6e8-d4223dcf2346","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"debcdac6-7ef3-5820-90b8-353614354fc7","slug":"changes","fullItemName":"Changes"},{"id":"32308918-ad23-5b7d-a1c5-7c7a4edf3e35","slug":"update","fullItemName":"Update"}]},{"id":"efc69a37-1a91-539d-b4ce-b1cfc1d48baf","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"09ce3910-2aa3-537d-97db-f473bf3f3c99","slug":"goals","fullItemName":"Goals"},{"id":"37776aed-67d4-5001-8e82-0fec56ecaa71","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2638b372-65f4-549c-9c2d-fff4cf1c933d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"df03f868-28e0-52a9-9f30-aecfccaa745c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bf290438-2d1b-5233-a43a-e3fe0cbccaab","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d66aeca6-f9ff-5104-94d3-d115d20ad7d1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5f9559ed-2d1c-52f3-ae50-cb983d1b7c7c","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"025302eb-268d-585c-b9a4-d83b4dbb0e5b","slug":"definition","fullItemName":"Definition"},{"id":"43d0a434-92b2-5c53-b4bd-f8ab32a8c0a3","slug":"causes","fullItemName":"Causes"},{"id":"0f04315e-ba03-5be7-a5dc-c724c1e3fe90","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ad49e37a-e725-5ad1-9e7b-f84a79627169","slug":"complications","fullItemName":"Complications"},{"id":"50cfb7dd-1ad7-5d22-9c7e-8472fb0af48c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"26dec6e1-8806-50b7-869d-1e010fa15e89","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"1f674962-dade-5ce5-9b92-60820da005f7","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"f384b060-7f9e-593e-8a77-6bbf957fd0c4","slug":"assessment","fullItemName":"Assessment"},{"id":"2b98bc5c-ae88-522e-89c4-79e05d301c3f","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"521d1a4a-9184-5872-ab66-2a3fed074cc8","slug":"management","fullItemName":"Management","subChapters":[{"id":"ca5edad5-d74c-565f-b254-2c59bed62420","slug":"seborrhoeic-dermatitis-infants","fullItemName":"Scenario: Seborrhoeic dermatitis - infants"},{"id":"4172af9c-8f8b-5bcc-a160-ca83f520099c","slug":"seborrhoeic-dermatitis-scalp-beard","fullItemName":"Scenario: Seborrhoeic dermatitis - scalp and beard"},{"id":"ad81b0ed-2e0c-5a1d-a7a0-e823d40d7ca4","slug":"seborrhoeic-dermatitis-face-body","fullItemName":"Scenario: Seborrhoeic dermatitis - face and body"},{"id":"715da1f8-f458-5eec-96e8-85e22060d505","slug":"seborrhoeic-dermatitis-severe-or-widespread","fullItemName":"Scenario: Seborrhoeic dermatitis - severe or widespread"}]},{"id":"bac53cb4-0b97-5d4b-8ce4-07a9584a5e4f","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"970b1e50-a3fc-503d-bbe8-29ecfa575d20","slug":"products-available-otc","fullItemName":"Products available OTC"},{"id":"9b1c8434-e7ce-5cd0-8c49-9e1076fbcecb","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"d35c5c70-d96b-5a9a-a708-2e051cf3cece","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"}]},{"id":"b5cb8438-116a-5790-9b0f-2a480c577056","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"03823e51-3fec-53db-8dde-3fbe6e94526c","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"364fda13-808d-599d-84cd-2b31ed7d0d94","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fd9a5e23-6ee9-503f-bbc4-7239d8555e0e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1120e62a-fd06-536e-8caf-945332e36549","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"214850c4-e7af-5924-9a63-09325facd062","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"bfa9b404-d181-55eb-a3b2-8da0ee4edb43","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"5171db55-6873-590e-b670-2d66a4b1b1eb","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"b328d01a-a44a-57e1-8920-22321b4c6c8b","topicId":"67c69cb5-e030-443e-802f-758ce0fe90f8","topicName":"Seborrhoeic dermatitis","slug":"seborrhoeic-dermatitis","aliases":[],"topicSummary":"Seborrhoeic dermatitis is a common inflammation of the skin occurring in areas rich in sebaceous glands","lastRevised":"Last revised in February 2019","nextPlannedReviewBy":"2024-02-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2024-02","nextPlannedReviewByDisplay":"February 2024","specialities":[{"id":"e9e3ea2b-52b8-5242-bc9d-24052ea8647a","name":"Child health","slug":"child-health"},{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"}],"chapters":[{"id":"2c32aabf-f751-57c2-9fb1-bfd7e4c7e58d","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"96bfb0b4-09f0-5525-aaf3-ca2354a87cb4","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"9bf8c16e-f128-5c6a-b6e8-d4223dcf2346","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"debcdac6-7ef3-5820-90b8-353614354fc7","slug":"changes","fullItemName":"Changes"},{"id":"32308918-ad23-5b7d-a1c5-7c7a4edf3e35","slug":"update","fullItemName":"Update"}]},{"id":"efc69a37-1a91-539d-b4ce-b1cfc1d48baf","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"09ce3910-2aa3-537d-97db-f473bf3f3c99","slug":"goals","fullItemName":"Goals"},{"id":"37776aed-67d4-5001-8e82-0fec56ecaa71","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2638b372-65f4-549c-9c2d-fff4cf1c933d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"df03f868-28e0-52a9-9f30-aecfccaa745c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bf290438-2d1b-5233-a43a-e3fe0cbccaab","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d66aeca6-f9ff-5104-94d3-d115d20ad7d1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5f9559ed-2d1c-52f3-ae50-cb983d1b7c7c","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"025302eb-268d-585c-b9a4-d83b4dbb0e5b","slug":"definition","fullItemName":"Definition"},{"id":"43d0a434-92b2-5c53-b4bd-f8ab32a8c0a3","slug":"causes","fullItemName":"Causes"},{"id":"0f04315e-ba03-5be7-a5dc-c724c1e3fe90","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ad49e37a-e725-5ad1-9e7b-f84a79627169","slug":"complications","fullItemName":"Complications"},{"id":"50cfb7dd-1ad7-5d22-9c7e-8472fb0af48c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"26dec6e1-8806-50b7-869d-1e010fa15e89","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"1f674962-dade-5ce5-9b92-60820da005f7","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"f384b060-7f9e-593e-8a77-6bbf957fd0c4","slug":"assessment","fullItemName":"Assessment"},{"id":"2b98bc5c-ae88-522e-89c4-79e05d301c3f","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"521d1a4a-9184-5872-ab66-2a3fed074cc8","slug":"management","fullItemName":"Management","subChapters":[{"id":"ca5edad5-d74c-565f-b254-2c59bed62420","slug":"seborrhoeic-dermatitis-infants","fullItemName":"Scenario: Seborrhoeic dermatitis - infants"},{"id":"4172af9c-8f8b-5bcc-a160-ca83f520099c","slug":"seborrhoeic-dermatitis-scalp-beard","fullItemName":"Scenario: Seborrhoeic dermatitis - scalp and beard"},{"id":"ad81b0ed-2e0c-5a1d-a7a0-e823d40d7ca4","slug":"seborrhoeic-dermatitis-face-body","fullItemName":"Scenario: Seborrhoeic dermatitis - face and body"},{"id":"715da1f8-f458-5eec-96e8-85e22060d505","slug":"seborrhoeic-dermatitis-severe-or-widespread","fullItemName":"Scenario: Seborrhoeic dermatitis - severe or widespread"}]},{"id":"bac53cb4-0b97-5d4b-8ce4-07a9584a5e4f","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"970b1e50-a3fc-503d-bbe8-29ecfa575d20","slug":"products-available-otc","fullItemName":"Products available OTC"},{"id":"9b1c8434-e7ce-5cd0-8c49-9e1076fbcecb","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"d35c5c70-d96b-5a9a-a708-2e051cf3cece","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"}]},{"id":"b5cb8438-116a-5790-9b0f-2a480c577056","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"03823e51-3fec-53db-8dde-3fbe6e94526c","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"364fda13-808d-599d-84cd-2b31ed7d0d94","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fd9a5e23-6ee9-503f-bbc4-7239d8555e0e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1120e62a-fd06-536e-8caf-945332e36549","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"214850c4-e7af-5924-9a63-09325facd062","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"bfa9b404-d181-55eb-a3b2-8da0ee4edb43","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"5171db55-6873-590e-b670-2d66a4b1b1eb","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"b328d01a-a44a-57e1-8920-22321b4c6c8b"}},"staticQueryHashes":["3666801979"]}